Sign in

CIK 0001680581

  • Non-accelerated filer
  • Smaller reporting company

Fulcrum Therapeutics, Inc.

Sign in to watch
Ticker
FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474839948
Phone
+1 617-651-8851
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-08-10 Moxham Christopher Chief Scientific Officer Exercise or conversion +20,714 $7.84 $162K 20,714
2021-08-10 Moxham Christopher Chief Scientific Officer Sale −20,714 $17.00 $352K 0
2021-08-10 Moxham Christopher Chief Scientific Officer Exercise or conversion +31,071 $7.84 $244K 31,071
2021-08-10 Moxham Christopher Chief Scientific Officer Sale −31,071 $18.00 $559K 0
2021-08-10 Moxham Christopher Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −20,714 103,572
2021-08-10 Moxham Christopher Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −31,071 72,501
2021-08-10 Stuart Bryan Exercise or conversion +32,000 $7.84 $251K 32,000
2021-08-10 Stuart Bryan Sale −32,000 $17.50 $560K 0
2021-08-10 Stuart Bryan Exercise or conversion · Stock Option (right to buy) −32,000 271,571
2021-06-28 Morabito Christopher Chief Medical Officer Purchase +1,100 $9.16 $10K 1,100
2021-06-28 Oltmans Curtis Gale SVP, General Counsel Purchase +1,088 $9.01 $10K 1,088
2021-06-28 Thomson Peter G. VP Finance & Accounting Purchase +2,300 $9.00 $21K 2,300
2021-06-28 GERAGHTY JAMES A Director Purchase +10,000 $9.16 $92K 90,714
2021-06-09 Collins James J. Director Grant or award · Stock Option (right to buy) +15,000 15,000
2021-06-09 LEVIN MARK J Director Grant or award · Stock Option (right to buy) +15,000 15,000
2021-06-09 GERAGHTY JAMES A Director Grant or award · Stock Option (right to buy) +15,000 15,000
2021-06-09 Ezekowitz Alan Director Grant or award · Stock Option (right to buy) +15,000 15,000
2021-06-09 Haviland Kate Director Grant or award · Stock Option (right to buy) +15,000 15,000
2021-06-09 Dorton Katina Director Grant or award · Stock Option (right to buy) +15,000 15,000
2021-05-10 Morabito Christopher Chief Medical Officer Grant or award · Stock Option (right to buy) +163,000 163,000

Page 8 of 15 · 291 trades